Vittorio Stefoni Selected Research

Vittorio Stefoni Research Topics

Disease

23	Lymphoma (Lymphomas) 01/2021 - 08/2002
16	Hodgkin Disease (Hodgkin's Disease) 04/2022 - 08/2002
16	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 08/2002
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 03/2005
8	B-Cell Lymphoma (Lymphoma, B Cell) 09/2021 - 09/2003
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 11/2008
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 12/2005
5	Neoplasms (Cancer) 01/2021 - 10/2005
5	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020 - 05/2003
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 12/2003
4	Hairy Cell Leukemia 10/2021 - 03/2004
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2014 - 09/2005
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 01/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 09/2015
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017 - 12/2016
2	Rare Diseases (Rare Disease) 11/2014 - 12/2013
2	Mycosis Fungoides 12/2005 - 09/2005
1	Thrombotic Thrombocytopenic Purpura 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	IgA Deficiency 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Infections 01/2021
1	Thrombophilia 12/2020
1	Enteropathy-Associated T-Cell Lymphoma 01/2019
1	Multiple Myeloma 06/2018
1	Plasmablastic Lymphoma 06/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 11/2015
1	Erdheim-Chester Disease 07/2012
1	Neutropenia 02/2008
1	Thrombocytopenia (Thrombopenia) 02/2008
1	Pathologic Complete Response 06/2006
1	Sezary Syndrome (Sezary Erythroderma) 12/2005

Drug/Important Bio-Agent (IBA)

15	Rituximab (Mabthera)FDA Link 01/2021 - 09/2003
9	fludarabineIBA 06/2016 - 12/2003
7	Brentuximab VedotinIBA 04/2022 - 12/2016
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2012 - 05/2004
6	Lenalidomide (CC 5013)FDA Link 01/2021 - 08/2011
6	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2016 - 02/2008
6	Prednisone (Sone)FDA LinkGeneric 07/2012 - 12/2003
5	ibritumomab tiuxetan (Zevalin)FDA Link 01/2020 - 02/2008
5	Vincristine (Oncovin)FDA LinkGeneric 07/2012 - 05/2004
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2012 - 07/2005
4	Etoposide (VP 16)FDA LinkGeneric 07/2012 - 08/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010 - 06/2008
3	ibrutinibIBA 12/2021 - 01/2018
3	Cladribine FDA LinkGeneric 10/2021 - 03/2004
3	Bortezomib (Velcade)FDA Link 01/2018 - 09/2007
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2012 - 06/2008
3	Yttrium-90IBA 08/2010 - 02/2008
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2020
2	Gemcitabine FDA Link 11/2014 - 12/2005
2	Interferon-alpha (Interferon Alfa)IBA 10/2010 - 12/2003
2	Glucose (Dextrose)FDA LinkGeneric 11/2009 - 06/2006
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 10/2009
2	Ifosfamide FDA LinkGeneric 11/2008 - 08/2002
2	Epirubicin (Ellence)FDA LinkGeneric 11/2008 - 08/2002
1	idelalisibIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	romidepsin (FK228)FDA Link 01/2022
1	Cyclin D1IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	AgglutininsIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Monoclonal AntibodiesIBA 12/2020
1	cyclopropapyrroloindoleIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 12/2020
1	Bendamustine Hydrochloride FDA Link 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	alovudineIBA 07/2019
1	Thalidomide (Thalomid)FDA Link 06/2018
1	Cytostatic AgentsIBA 06/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2018
1	Biosimilar PharmaceuticalsIBA 02/2018
1	temsirolimus FDA Link 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 12/2013
1	Leucovorin (Folinic Acid)FDA Link 10/2009
1	Dacarbazine (DIC)FDA LinkGeneric 06/2008
1	Vinblastine (Vinblastine Sulfate)FDA Link 06/2008
1	Proteasome InhibitorsIBA 09/2007
1	Hemoglobins (Hemoglobin)IBA 10/2005
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2005

Therapy/Procedure

20	Therapeutics 04/2022 - 08/2002
16	Drug Therapy (Chemotherapy) 09/2021 - 08/2002
10	Stem Cell Transplantation 04/2022 - 11/2008
6	Autologous Transplantation 04/2022 - 05/2003
6	Radioimmunotherapy 06/2016 - 02/2008
4	Radiotherapy 12/2015 - 07/2003
4	Salvage Therapy 12/2013 - 02/2004
2	Immunotherapy 10/2020 - 01/2018
2	Aftercare (After-Treatment) 11/2009 - 03/2004
1	Bridge Therapy 01/2021
1	Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2020
1	MACOP-B regimen 11/2015
1	Splenectomy 10/2010